Home›Stock Screener›Aptus Pharma

Aptus Pharma Share Price Today | Stock Price & Aptus Pharma Share Screener

APPL Consumer Durables

Track the current Aptus Pharma share price and stock price live with TickJournal's free stock screener. Track APPL market cap trends to gauge the company's total market size. Use the Aptus Pharma stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Aptus Pharma opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Aptus Pharma Market Cap ₹853.17 Cr.
APPL P/E Ratio (TTM) -
Aptus Pharma P/B Ratio 36.18
EPS (TTM) ₹7.78
Dividend Yield -
Debt to Equity 0.58
APPL 52 Week High -
Aptus Pharma 52 Week Low -
Operating Margin -
Profit Margin -
APPL Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹44.00
Total Equity ₹23.00

Aptus Pharma Share Price Chart

Track the current stock price of Aptus Pharma with an interactive chart. Analyse APPL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Aptus Pharma stock quote in one place.

Aptus Pharma Company Profile - Fundamental Screener

Screen Aptus Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for APPL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Consumer Discretionary sector and the Consumer Durables industry, and it trades under ISIN INE15XJ01010.

Company Details

Classification

Sector Consumer Discretionary
Industry Consumer Durables
Sub-Sector Consumer Durables
Segment E

Identifiers and Leadership

ISIN INE15XJ01010

Aptus Pharma Balance Sheet Screener

Screen APPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹44, up from ₹22 in 2025.

Latest statistics put total assets at ₹44 and shareholder funds at ₹23, with a leverage ratio of 0.58.

Item 2026 2025 2024 2023

Assets

Total Assets 44 22 10 6
Current Assets 0 0 0 0
Fixed Assets 3 1 1 1

Liabilities

Total Liabilities 0 0 0 0
Current Liabilities 1 3 4 2
Non-Current Liabilities 0 0 0 0

Shareholders' Equity

Total Equity 23 7 2 1
Share Capital 7 5 0 0
Reserves & Surplus 17 2 2 1

Aptus Pharma Income Statement Screener - Profit & Revenue Analysis

Screen Aptus Pharma income statement and profit fundamentals. Analyze APPL quarterly results. Aptus Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹47 and net profit of ₹5.

Item None-None 2026-March 2025-March 2024-March 2023-March

Revenue and Expenses

Revenue 0 47 25 18 14
Expenses 0 39 20 16 13

Operating Costs and Margins

EBITDA 0 8 5 2 1
Operating Profit % 0.00% 16.00% 20.00% 9.00% 4.00%
Depreciation 0 0 0 0 0
Interest 0 1 1 0 0

Profit and Earnings

Profit Before Tax 0 6 4 1 0
Tax 0 2 1 0 0
Net Profit 0 5 3 1 0
EPS 0.00 7.78 6.37 5.32 1.30

Aptus Pharma Cash Flow Screener - Liquidity Fundamentals

Screen APPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹6, and net cash flow was an outflow of ₹4.

Over the same period, investing activities used ₹6 and financing activities provided ₹8.

Item 2026-March 2025-March 2024-March 2023-March

Cash from Operations and Investing

Operating Activities -6 -2 -2 0
Investing Activities -6 -1 0 0

Financing and Net Cash

Financing Activities 8 7 3 1
Net Cash Flow -4 4 0 0

Aptus Pharma Shareholding Pattern Screener

See Aptus Pharma shareholding pattern with promoter, FII, and DII holdings. Check Aptus Pharma promoter holding and ownership changes for APPL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 72.89%, foreign institutions 0.00%, domestic institutions 0.00% and the public 23.47%, spread across 337 shareholders.

The shareholder count was 337 in 2026-Mar, compared with 356 in 2026-May.

Item 2026-Mar 2026-May 2026-Jun 2026-Sept 2025-Jun 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 72.89% 72.89% 72.89% 72.89% 72.89% 72.89% 72.89%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 10.03% 10.03% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 2.80% 2.80% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.47% 23.76% 24.03% 24.55% 11.55% 11.55% 22.97%
Other Holding 3.64% 3.35% 3.08% 2.57% 2.74% 2.74% 4.14%
Shareholder Count 337 356 686 995 9 9 302

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Aptus Pharma. Aptus Pharma dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Aptus Pharma.

Aptus Pharma Stock Index Membership - Nifty & Sensex

See which indices include Aptus Pharma stock. Check APPL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Aptus Pharma is not part of any tracked indices.
Only major market indices are tracked in our system.

Aptus Pharma Market Events Screener - Corporate Actions

Get Aptus Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Aptus Pharma stock events that may affect APPL share price, along with derivatives, futures and options activity and sector gainers.

5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 20, 2026, with a record date of October 20, 2026.

It is followed by Annual General Meeting dated September 14, 2026 and Bonus dated May 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-20 2026-10-20 Quarterly Result Announcement NA 6.11%
2026-09-14 2026-09-14 Annual General Meeting NA 21.48%
2026-05-12 2026-05-12 Bonus 3:2 16.32%
2026-04-27 2026-04-27 Quarterly Result Announcement NA -4.87%
2025-11-10 2025-11-10 Quarterly Result Announcement NA 12.62%

Aptus Pharma Competitors Screener - Peer Stocks Comparison

Screen APPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Consumer Discretionary sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Titan 435,725 62.00 88,136 44.62% 5,073 62.87
Asian Paints 251,789 50.50 36,307 5.31% 4,395 71.07
LG Electronics 116,837 60.80 24,933 1.23% 1,685 50.76
Dixon Technologies 80,017 45.00 49,586 27.53% 1,644 60.69
Havells 73,738 44.20 23,022 4.26% 1,689 66.59
Kalyan Jewellers 70,511 45.70 35,951 42.72% 1,350 69.01
Berger Paints 55,840 44.60 11,987 2.98% 1,128 52.56
Voltas 38,015 83.10 14,483 -7.97% 370 62.86
Blue Star 33,063 62.50 12,464 3.50% 527 55.42
Metro Brands 22,867 54.30 2,968 14.13% 416 46.75

Aptus Pharma Company Announcements - News & Reports Screener

Screen APPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 14, 2026.

The next most recent announcements are dated November 6, 2026 and October 30, 2026.

Date Update Actions
2026-11-14 Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Equity Shares On Preferential Basis Under Regulation 30 Of SEBI LODR Regulations 2015 -
2026-11-06 Board Meeting Intimation for Intimation Of Board Meeting For Allotment Of Equity Shares On Preferential Basis -
2026-10-30 Receipt Of In-Principle Approval For Preferential Issue -
2026-10-29 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-10-26 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-10-23 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-10-21 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-20 Financial Results For The Half Year Ended 30Th September2026 -
2026-10-20 Board Meeting Outcome for Outcome Of Board Meeting Held On 20.10.2026 Along With Financial Results For Half Year Ended 30Th September 2026 -
2026-10-15 Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30 2026 And Closure Of Trading Window -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Closure of Trading Window -
2026-09-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-14 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-14 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING -
2026-08-24 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-21 Announcement under Regulation 30 (LODR)-Investor Presentation -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 36.18. Market capitalisation stands at ₹853.17 Cr. The company operates in the Consumer Discretionary sector, in the Consumer Durables industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 19, 2026. This page covers 4 balance sheet periods, 5 income statement periods, 4 cash flow years and 7 shareholding periods. Information is provided for research and is not investment advice.